HAKIM NASRAT A (CEO & President) reported 1 transaction at ELITE PHARMACEUTICALS INC /NV/
Review the transaction codes below to understand the nature of each event.
Filed: 8/26/2020ACC: 0001583742-20-000002
DirectorOfficer10% Owner· CEO & President
Since Aug 2020
+158.02M
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
158.02M acquired · 24.03 disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
+158.02M
Price / share
—
Trade value
—
% of position
1736.9%
8/24/2020
9.10M→167.11M
Total
Net shares
+158.02M
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/24/2020 | C · Conversion | +158.02M | — | — | 1736.9% | 9.10M | 167.11M |
| Total | +158.02M | $0.00 | ||||||
Derivative Transactions1
Series J Convertible Preferred Shares
Direct
Converts to
Common Stock
158.02M shares
Shares
−24.03
Strike price
Held after
0.00
Exercisable
—
8/24/2020
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Series J Convertible Preferred Shares Direct | Common Stock158.02M shares | 8/24/2020 | C · Conversion | −24.03 | — | 0.00 |
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned2.70M
Total
2.70M indirect2.70M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 2.70M | Indirect |
| Total | 2.70M | 2.70M indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported